Total-body Dynamic Imaging and Kinetic Modeling of 18F-AraG in Healthy Individuals and a Non-Small Cell Lung Cancer Patient Undergoing Anti-PD-1 Immunotherapy
View ORCID ProfileNegar Omidvari, Jelena Levi, Yasser G Abdelhafez, Yiran Wang, Lorenzo Nardo, Megan E Daly, Guobao Wang, Simon R Cherry
doi: https://doi.org/10.1101/2023.09.22.23295860
Negar Omidvari
1Department of Biomedical Engineering, University of California Davis, Davis, CA, USA
Jelena Levi
2CellSight Technologies Inc., San Francisco, CA, USA
Yasser G Abdelhafez
3Department of Radiology, University of California Davis Medical Center, Sacramento, CA, USA
4Radiotherapy and Nuclear Medicine Department, South Egypt Cancer Institute, Assiut University, Egypt
Yiran Wang
3Department of Radiology, University of California Davis Medical Center, Sacramento, CA, USA
1Department of Biomedical Engineering, University of California Davis, Davis, CA, USA
Lorenzo Nardo
3Department of Radiology, University of California Davis Medical Center, Sacramento, CA, USA
Megan E Daly
5Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center School of Medicine, Sacramento, CA, USA
Guobao Wang
3Department of Radiology, University of California Davis Medical Center, Sacramento, CA, USA
Simon R Cherry
1Department of Biomedical Engineering, University of California Davis, Davis, CA, USA
3Department of Radiology, University of California Davis Medical Center, Sacramento, CA, USA
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted September 23, 2023.
Total-body Dynamic Imaging and Kinetic Modeling of 18F-AraG in Healthy Individuals and a Non-Small Cell Lung Cancer Patient Undergoing Anti-PD-1 Immunotherapy
Negar Omidvari, Jelena Levi, Yasser G Abdelhafez, Yiran Wang, Lorenzo Nardo, Megan E Daly, Guobao Wang, Simon R Cherry
medRxiv 2023.09.22.23295860; doi: https://doi.org/10.1101/2023.09.22.23295860
Total-body Dynamic Imaging and Kinetic Modeling of 18F-AraG in Healthy Individuals and a Non-Small Cell Lung Cancer Patient Undergoing Anti-PD-1 Immunotherapy
Negar Omidvari, Jelena Levi, Yasser G Abdelhafez, Yiran Wang, Lorenzo Nardo, Megan E Daly, Guobao Wang, Simon R Cherry
medRxiv 2023.09.22.23295860; doi: https://doi.org/10.1101/2023.09.22.23295860
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2661)
- Dermatology (224)
- Emergency Medicine (402)
- Epidemiology (12264)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4122)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2670)
- Health Policy (1008)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (441)
- Neurology (3912)
- Nursing (210)
- Nutrition (582)
- Oncology (2048)
- Ophthalmology (587)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (455)
- Public and Global Health (6551)
- Radiology and Imaging (1410)
- Respiratory Medicine (872)
- Rheumatology (412)
- Sports Medicine (344)
- Surgery (452)
- Toxicology (54)
- Transplantation (186)
- Urology (167)